A pharmaceutical composition comprising a pharmaceutically effective amount of a peptide comprising an amino acid sequence of SEQUENCE ID NO. 1 or a variant thereof. Uses of the pharmaceutical composition in the treatment of metabolic disorders, diseases characterised by muscle wasting or reduced protein synthesis, and diseases mediated by oxidative stress, are also disclosed.